359090 — C&R Research Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual cashflow statement for C&R Research, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	7 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final
Net Income/Starting Line	-19.3	—	3,928	5,560
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	-9.29	—	960	794
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	0.076	1,566	-3,012	-3,986
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-28.5	2,249	2,523	3,512
Capital Expenditures	—	-1,281	-1,258	-219
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-14,700	14,772	-8,880	-1,578
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-14,700	13,491	-10,138	-1,797
Financing Cash Flow Items	1,006	—	-3.52	263
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	14,788	-919	-5,316	-959
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	59.1	14,821	-12,937	747